Finding 400913 (2022-006)

Material Weakness
Requirement
ABH
Questioned Costs
-
Year
2022
Accepted
2024-06-14

AI Summary

  • Core Issue: The Clinic lacks proper internal controls for reviewing and approving expenditure listings related to federal awards.
  • Impacted Requirements: This violates 2 CFR 200.303 (a), which mandates effective internal controls for compliance with federal regulations.
  • Recommended Follow-Up: Enhance internal control policies to ensure all expenditure reviews and approvals are documented and retained.

Finding Text

Department of Homeland Security Federal Assistance Listing #97.036 COVID‐19 Disaster Grants – Public Assistance Activities Allowed or Unallowed and Allowable Costs/Costs Principles and Period of Performance Material Weakness in Internal Control Over Compliance Criteria: 2 CFR 200.303 (a) establishes that the auditee must establish and maintain effective internal control over federal awards that provides reasonable assurance that the entity is managing the federal award in compliance with federal statutes, regulations and conditions of the federal award. Condition: During our testing, it was noted that the review and approval of the expenditure listings was not retained. Cause: The Clinic did not have an internal control policy in place to ensure the review and approval of the expenditure listings was documented and retained. Effect: The lack of adequate policies governing review and approval over the expenditure listings increases the risk that employees participating in the federal award administration may not be able to detect and correct noncompliance in a timely manner. Questioned Costs: None reported. Context/Sampling: A nonstatistical sample of 42 of 209 expenditures were selected for testing, which accounted for $120,934 of $346,290 direct program expenditures. None of the expenditures contained evidence of a secondary review to verify that expenditures met the terms and conditions of the program. Repeat Finding from Prior Years: No Recommendation: We recommend the Clinic enhance internal control policies to ensure the expenditure listings are reviewed and approved and all of that information is retained to ensure that all payments are necessary, correct, and meet the requirements of the federal program. View of Responsible Officials: Management agrees with the finding.

Categories

Allowable Costs / Cost Principles Material Weakness Period of Performance Internal Control / Segregation of Duties

Other Findings in this Audit

  • 400902 2022-004
    Material Weakness
  • 400903 2022-005
    Material Weakness
  • 400904 2022-004
    Material Weakness
  • 400905 2022-006
    Material Weakness
  • 400906 2022-004
    Material Weakness
  • 400907 2022-006
    Material Weakness
  • 400908 2022-004
    Material Weakness
  • 400909 2022-006
    Material Weakness
  • 400910 2022-004
    Material Weakness
  • 400911 2022-006
    Material Weakness
  • 400912 2022-004
    Material Weakness
  • 977344 2022-004
    Material Weakness
  • 977345 2022-005
    Material Weakness
  • 977346 2022-004
    Material Weakness
  • 977347 2022-006
    Material Weakness
  • 977348 2022-004
    Material Weakness
  • 977349 2022-006
    Material Weakness
  • 977350 2022-004
    Material Weakness
  • 977351 2022-006
    Material Weakness
  • 977352 2022-004
    Material Weakness
  • 977353 2022-006
    Material Weakness
  • 977354 2022-004
    Material Weakness
  • 977355 2022-006
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
93.788 Opioid Str $360,804
93.697 Covid-19 Testing for Rural Health Clinics $200,000
93.498 Provider Relief Fund $157,739
93.912 Rural Health Care Services Outreach, Rural Health Network Development and Small Health Care Provider Quality Improvement $99,058
97.036 Disaster Grants - Public Assistance (presidentially Declared Disasters) $82,851